Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-08-01 2019-06-27
Drug Identification Number 02011239 02011239
Brand name CARBOLITH CARBOLITH
Common or Proper name CARBOLITH CARBOLITH
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients LITHIUM CARBONATE LITHIUM CARBONATE
Strength(s) 600MG 600MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N05AN N05AN
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-06-25 2019-06-25
Estimated end date Unknown
Actual end date 2019-07-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments awaiting QA final release to market awaiting QA final release to market
Health Canada comments